The LiberHetica and BERC-Luso consortia will meet on the 26th March 2021 to discuss about Biomedical Ethics and Regulatory Capacity Building in Sub-Saharan African countries.

The LiberHetica and BERC-Luso are two projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) aimed at strenghting ethics and regulatory capacities for clinical trials by partnerships between African and European countries, and involving 5 Sub-Saharan African countries (Liberia, Angola, Guinea Bissau, Mozambique and Cape-Verde) and 2 European countries (U.K. and Portugal).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

NeuroSolve project obtained the Clinical Trial Ethical Approval in Zambia too!

After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

Neglected Tropical Diseases affect 1 in 5 people in the world

Neglected Tropical Diseases affect 1 in 5 people worldwide. Affecting over 1.7 billion people, the Neglected Tropical Diseases impair physical and cognitive development, contribute to mother and child illness and

African and European multidisciplinary researchers established an integrated consortium to develop a research project on the dengue and Zika viruses affecting Africa and the world

Dengue and Zika viruses are arboviruses primarily transmitted by Aedes mosquitoes. Dengue and Zika infectious disease frequently erupt in tropical and subtropical regions. Globalization coupled with climate change, significantly expedites their worldwide